Skip to main content
ANTEOTECH LTD logo

ANTEOTECH LTD — Investor Relations & Filings

Ticker · ADO ISIN · AU000000ADO8 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,280 across all filing types
Latest filing 2017-04-20 Regulatory Filings
Country AU Australia
Listing ASX ADO

About ANTEOTECH LTD

https://anteotech.com

AnteoTech Ltd is a surface chemistry company specializing in the development of proprietary nanoglue technology. The company focuses on two primary sectors: life sciences and energy. In the life sciences division, AnteoTech utilizes its AnteoBind molecular linker technology to enhance the performance of point-of-care diagnostic tests, bioprocessing, and assay development by improving the binding of biomolecules to synthetic surfaces. In the energy sector, the company develops advanced materials for lithium-ion batteries, specifically focusing on silicon anodes. Its AnteoX additive is designed to improve the electrochemical performance and structural stability of high-silicon content anodes, addressing capacity loss and cycle life challenges. The company's core value proposition lies in its ability to manipulate surface interfaces at the molecular level to optimize performance in complex chemical and biological environments.

Recent filings

Filing Released Lang Actions
Supporting Technology Readiness of Novel PoC Platform 2 pages 361.8KB
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 21 April 2017 from Anteo Diagnostics Limited. It discusses the completion of a milestone in a technology partnership study related to point of care diagnostic systems, highlighting technical progress and future plans. There are no financial statements, regulatory form references, or detailed financial performance data. The content focuses on a project update and technology readiness rather than financial results or governance matters. The document length is 4199 characters, which is relatively short and reads like a press release or corporate update. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a regulatory filing or certification. The best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous company announcements that do not fit other specific categories.
2017-04-20 English
Earn Out For Purchase of DIAsource Finalised 2 pages 362.4KB
Capital/Financing Update Classification · 95% confidence The document is a corporate announcement dated 18 April 2017 regarding the finalization of an Earn Out payment related to the purchase of DIAsource. It discusses the final Earn Out amount, payment extension, and changes in equity components. The content focuses on a specific financing and payment update related to a past acquisition, rather than presenting full financial statements or comprehensive financial performance data. The document length is relatively short (3270 characters) and does not contain detailed financial reports or management analysis. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2017-04-17 English
Appendix 3B 11 pages 970.4KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B' and is an announcement related to the issue of new securities, specifically unlisted options, by Anteo Diagnostics Limited. It includes detailed information about the class, number, terms, issue price, purpose of the issue, and compliance with ASX rules regarding placement capacity under rules 7.1 and 7.1A. The document is a formal notification to the Australian Securities Exchange (ASX) about the issuance and quotation of additional securities. It does not contain financial statements, management discussion, or audit information, but rather focuses on capital raising and securities issuance details. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2017-04-12 English
Bergen Investment Facility Terminated 1 page 377.0K
Capital/Financing Update Classification · 95% confidence The document is a short announcement dated 12 April 2017 regarding the termination of an investment facility between Anteo Diagnostics Limited and Bergen Global Opportunity Fund. It discusses the company's securing of additional working capital and the termination of a previously announced investment facility. The document does not contain financial statements, detailed financial analysis, or comprehensive report content. It is a brief update on financing activity and company status related to capital structure. Given the content and length (2398 characters), it fits best as a Capital/Financing Update rather than a full financial report or other categories. Therefore, the appropriate classification is CAP (Capital/Financing Update).
2017-04-11 English
Anteo Progresses Second Battery Patent to PCT 2 pages 391.9KB
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 11 April 2017 about Anteo Diagnostics progressing a second battery patent to the PCT phase. It discusses patent applications, commercialisation strategy, and research activities related to energy applications. There are no financial statements, regulatory certifications, voting results, or management changes. The content is a corporate update on intellectual property and business development rather than a formal financial report or regulatory filing. The document length is under 5,000 characters and reads like a press release or general regulatory announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous company announcements that do not fit other specific categories.
2017-04-10 English
Anteo Secures Working Capital & Extension to Earn Out 2 pages 402.8KB
Capital/Financing Update Classification · 95% confidence The document is an announcement dated 06 April 2017 regarding Anteo Diagnostics Limited securing additional working capital through unsecured loans from shareholders, board members, and the CEO. It also announces an extension to the Earn Out payment deadline. The content focuses on financing activities, loan terms, and corporate funding arrangements. There are no financial statements, detailed financial performance data, or regulatory certifications present. The document is not a full financial report but rather an update on financing and capital structure changes. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 4363 characters, which is consistent with an announcement rather than a full report.
2017-04-05 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.